US Patent Issued to Academia Sinica on April 14 for "Treatment of coronavirus infection with Flt3 receptor interacting lectin (FRIL)" (Taiwanese Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,644, issued on April 14, was assigned to Academia Sinica (Taipei, Taiwan).

"Treatment of coronavirus infection with Flt3 receptor interacting lectin (FRIL)" was invented by Che Ma (Taipei, Taiwan) and Jia-Tsrong Jan (New Taipei City, Taiwan).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein is a method for treating or preventing a coronavirus infection, which comprises administering to a subject in need thereof an effective amount of a composition comprising Flt3 receptor interacting lectin (FRIL) from Lablab purpureus. Also disclosed is a pharmaceutical composition comprising a pharmaceutically acceptable excipient, a Lablab purpureus...